{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:23:55Z","timestamp":1789849435342,"version":"4.0.1"},"reference-count":16,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center(Korea)","doi-asserted-by":"crossref","award":["NCC- 1710322-1 and 1810301-1"],"award-info":[{"award-number":["NCC- 1710322-1 and 1810301-1"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210019","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T18:31:34Z","timestamp":1546281094000},"page":"e0210019","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?"],"prefix":"10.1371","volume":"13","author":[{"given":"Hae","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ju","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1503-1075","authenticated-orcid":true,"given":"Sung Hoon","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5495\/wjcid.v6.i3.37","article-title":"Clinical research in febrile neutropenia in cancer patients: Past achievements and perspectives for the future","volume":"6","author":"J Klastersky","year":"2016","journal-title":"World Journal of Clinical Infectious Diseases"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/clinids\/19.3.522","article-title":"Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms","volume":"19","author":"IA Malik","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000012019","article-title":"Outpatient treatment of neutropenic fever with oral antibiotics and granulocyte colony-stimulating factor","volume":"57","author":"C Papadimitris","year":"1999","journal-title":"Oncology"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/cncr.21089","article-title":"Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin","volume":"103","author":"G Chamilos","year":"2005","journal-title":"Cancer"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/oxfordjournals.annonc.a057996","article-title":"Home treatment of febrile neutropenia: an empirical oral antibiotic regimen","volume":"2","author":"M Gardembas-Pain","year":"1991","journal-title":"Ann Oncol"},{"issue":"9","key":"ref6","first-page":"657","article-title":"Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients","volume":"12","author":"CP Escalante","year":"2004","journal-title":"Support Care Cancer"},{"key":"ref7","first-page":"CD003992","article-title":"Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients","volume":"10","author":"L Vidal","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"25","key":"ref8","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1200\/JCO.2005.03.9909","article-title":"Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications","volume":"24","author":"J Klastersky","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00520-007-0334-8","article-title":"Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice","volume":"16","author":"H Innes","year":"2008","journal-title":"Support Care Cancer"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/bjc.2011.284","article-title":"Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients","volume":"105","author":"A Carmona-Bayonas","year":"2011","journal-title":"Br J Cancer"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JCO.2014.57.2347","article-title":"Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study","volume":"33","author":"A Carmona-Bayonas","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.annemergmed.2016.11.007","article-title":"Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department","volume":"69","author":"CJ Coyne","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/hr.2010.241","article-title":"Diurnal blood pressure variation and related behavioral factors","volume":"34","author":"Y Kawano","year":"2011","journal-title":"Hypertens Res"},{"issue":"Suppl 1","key":"ref14","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenic cancer patients","volume":"30","author":"J Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7812\/TPP\/14-188","article-title":"Utility of the Multinational Association for Supportive Care in Cancer (MASCC) Risk Index Score as a Criterion for Nonadmission in Febrile Neutropenic Patients with Solid Tumors","volume":"19","author":"RA Bitar","year":"2015","journal-title":"The Permanente journal"},{"issue":"5","key":"ref16","first-page":"1465","article-title":"Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents","volume":"26","author":"S Ahn","year":"2018","journal-title":"Support Care Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T11:44:12Z","timestamp":1662723852000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210019"}},"subtitle":[],"editor":[{"given":"Robert S","family":"Benjamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210019","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}